Researchers have demonstrated that an AI-driven diagnostic device can compress the time taken to identify autism spectrum disorder (ASD) compared with conventional clinical evaluations, according to findings from a recent study. Autism diagnosis often involves lengthy assessments by multidisciplinary teams, causing delays in support and intervention, especially in areas with limited specialist access.

The AI device uses machine learning algorithms trained on patterns of behaviour, developmental markers and observational data to screen for autism indicators with high sensitivity. In clinical evaluations, the technology was shown to generate diagnostic recommendations in a fraction of the time required for standard assessments — making it especially valuable for primary care settings, community clinics, and remote health systems where autism specialists are scarce.

According to study authors, early and accurate detection is critical because it enables families to access therapeutic resources sooner, tailor educational strategies, and begin evidence-based interventions that improve long-term outcomes. Delays in autism diagnosis can compound developmental challenges and stress for caregivers, making technological solutions that speed assessment particularly impactful.

The AI device’s developers emphasise that the tool is designed to support, not replace, clinicians; it augments human evaluation by highlighting key markers and streamlining data interpretation. Integrating the AI assessment with clinical judgement may help standardise diagnostic pathways while reducing bottlenecks that currently prolong the process.

Experts say that AI-enhanced diagnostic support tools represent the future of developmental disorder assessments, where data-driven insights help clinicians make informed decisions faster. With validation across diverse populations and settings, such technologies could widen access to screening and help reduce disparities in autism care globally.